Registration
 
All news
Top Stories
Editors' Picks
Crypto
Financial News
Currencies
Market Voices
Companies
Regulators
Central Banks
Elena Nikulina
Elena Nikulina

Pacira BioSciences unveils support hub for caregivers addressing chronic pain

Pacira BioSciences unveils support hub for caregivers addressing chronic pain
Pacira BioSciences launches support center

Pacira BioSciences has introduced a new resource center aimed at supporting caregivers of individuals living with chronic pain.

The initiative is part of the company effort to expand assistance beyond patients to those directly involved in day-to-day care. The resource center provides guidance, educational materials, and practical support to improve outcomes for both caregivers and their loved ones. Details are being clarified.

The expansion of resources to caregivers aligns with Pacira BioSciences’ broader commitment to reimagining pain management strategies, underscoring themes previously examined in the company's pursuit of innovative solutions such as non opioid pain therapies to transform patient care.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Editor's Picks for You

FIFA World Cup on blockchain: Where football meets crypto
  • By Oleg Tkachenko
  • 19 hours ago
FIFA World Cup on blockchain: Where football meets crypto
Editors' Picks
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
  • By Pavlo Kot
  • Yesterday
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
Editors' Picks
Blockchain nation in crisis: How a power struggle split Liberland
  • By Pavlo Kot
  • 20.06.2026
Blockchain nation in crisis: How a power struggle split Liberland
Editors' Picks
All Editors' Top Picks

Latest Pacira News

Pacira BioSciences stock edges higher to $22.85 as employees gather for family night, Pacira BioSciences
  • By Ciaran Ryan
  • 16.06.2026
Pacira BioSciences stock edges higher to $22.85 as employees gather for family night, Pacira BioSciences
Companies
#Pacira
Pacira BioSciences advances non opioid pain therapies to transform patient care
  • By Hlib Chabaniuk
  • 13.03.2026
Pacira BioSciences advances non opioid pain therapies to transform patient care
Companies
#Pacira
All Pacira News
  • Oleg Tkachenko
  • 19 hours ago
FIFA World Cup on blockchain: Where football meets crypto
  • Pavlo Kot
  • Yesterday
Aliens, Satoshi, and Bitcoin: How the extraterrestrial theory emerged
  • Pavlo Kot
  • 20.06.2026
Blockchain nation in crisis: How a power struggle split Liberland
  • Eugene Komchuk
  • 19.06.2026
Shifting priorities: Governments back mining as businesses turn to AI
  • Mikhail Vnuchkov
  • 18.06.2026
Intel's comeback: Apple, Trump and the AI bet
  • Hanna Syniavska
  • 37 min ago
Anndy Lian: AI-related tokens drive market cap surge as meme coins fall
  • Dmytro Kharkov
  • 51 min ago
Shrinking team size led to revenue growth, MATT GRAY notes
  • Jose Antonio Gastelum
  • 57 min ago
Jordan Kerridge: Bitcoin trades between $63,500 support and $64,400 resistance
  • Parshwa Turakhiya
  • 57 min ago
IWM may pause after entering uptrend channel, Jonah Lupton notes
  • Artem Shendetskii
  • 1 hour ago
Top executives drove companies into bankruptcy, Dean Baker notes
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.
Top News
  • Olga Shendetskaya
  • 13 hours ago
ECB remains cautious on war and inflation risks
ECB remains cautious on war and inflation risks
  • Olga Shendetskaya
  • 16 hours ago
SpaceX shares slide as valuation questions grow
SpaceX shares slide as valuation questions grow
  • Ashutosh Sureka
  • 18 hours ago
UK political transition weighs on pound as Keir Starmer says he will resign
UK political transition weighs on pound as Keir Starmer says he will resign
  • Hanna Syniavska
  • 18 hours ago
U.S. futures fall as Iran risk weighs on markets
U.S. futures fall as Iran risk weighs on markets
  • Andrey Mastykin
  • 19 hours ago
SK Hynix passes Samsung as HBM demand surges
SK Hynix passes Samsung as HBM demand surges
Live News
  • Anton Kharitonov
  • Now
Alphabet faces new challenges in AI race
  • Mykhailo Ihnatenko
  • Now
Nvidia tests support as investors await Micron earnings
  • Anton Kharitonov
  • Now
Microsoft corrects as investors question AI investment payback
  • Anton Kharitonov
  • Now
Apple remains in bullish trend despite pullback
  • Anton Kharitonov
  • Now
Bitcoin holds range ahead of next directional move
Who We Are
Business Solutions
For Users
TU News
Popular Sections
Disclosures
CONTACT US
Legal
We are in Social Media
© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186
  • Risk disclosure:

    Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

    That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.

  • Disclaimer:

    Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

    Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.

  • Disclosure of advertisers and revenues:

    All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

    Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.

onepercentfortheplanet.org World Association of News Publishers https://gdpr.eu/ GDPR